Search Results - "Janssen, Jeroen J. W.M."
-
1
Targeting miRNA-551b, a “Stemness”-like microRNA, to Eradicate AML (Stem) Cells
Published in Blood (29-11-2018)“…Despite high complete remission (CR) rates achieved after chemotherapy, only 30-40% of patients with Acute Myeloid Leukemia (AML) survive five years after…”
Get full text
Journal Article -
2
Insulin-like Growth Factor Binding Protein 7 Activates the Retinoid Acid Differentiation Pathway in Acute Myeloid Leukemia Cells
Published in Blood (29-11-2018)“…Acute myeloid leukemia (AML) is characterized by the accumulation of malignant blasts with impaired transcriptional differentiation programs. Despite important…”
Get full text
Journal Article -
3
-
4
Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia
Published in Blood (01-03-2008)“…The HOVON cooperative study group performed a feasibility study of escalated imatinib and intravenous cytarabine in 165 patients with early chronic-phase…”
Get full text
Journal Article